Seeking Alpha

Seeking Alpha Portfolio App for iPad

4,742 people get MDT articles and Market Currents by email alert.

Get email alerts on MDT »

MDT

Medtronic Inc.

5/20/2013, 4:15 AM ET

Quote & Headlines Market Currents StockTalk

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 4:33 PM Medtronic (MDT) says data presented at the Heart Rhythm Society's 34th Annual Scientific Sessions show its Lead Integrity Alert software detected pace/sense lead issues in non-MDT leads at a greater rate than standard impedance monitoring alone. The analysis, which focused on BSX's Endotak leads, shows that for every one Endotak pace/sense lead issue detected by impedance monitoring, the LIA software detected four cases that were missed. Comment! [Healthcare]
Monday, April 29, 3:59 PM Vascular specialists at Carolinas HealthCare System in Charlotte, North Carolina, and the Cleveland Clinic in Ohio perform the initial implants of a novel stent graft system from Medtronic (MDT +1%) as part of an FDA initiative designed to encourage more early-stage clinical research on new medical devices in the U.S. The implants are among the first to be performed under the agency's early feasibility pilot program, which includes a total of nine medical devices from different companies. Comment! [Healthcare]
Monday, April 22, 8:43 AM Arca Biopharma (ABIO) soars 35% premarket. The company says it will collaborate with Medtronic (MDT) on a Phase 2b clinical trial for Gencaro, ABIO's lead developmental drug for the treatment of cardiac rhythm disorders. Comment! [Healthcare, On the Move]
Thursday, April 11, 1:48 PM Medtronic (MDT +1.3%) moves up today after saying it's initiated enrollment of the first patient in its SubQStim II clinical trial which uses peripheral nerve stimulation, also known as subcutaneous nerve stimulation, to reduce chronic, intractable post-surgical back pain. Comment! [Healthcare, On the Move]
Tuesday, April 9, 3:03 PM Medtronic (MDT +1.1%) gains after saying it's released its CardioGuide Implant System, a real-time navigation system for pacemakers and defibrillators in the U.S. and Canada. The system helps physicians determine the most appropriate location for left-ventricular lead placement by generating 3-D images of the cardiac veins. Enhanced software for the system will be commercially available later this year that also analyzes the motion of select cardiac vessels on the left side of the heart. Comment! [Healthcare]
Monday, February 25, 1:51 PM Medtronic (MDT -0.3%) says the FDA has approved the 34mm and 38mm lengths of its Resolute Integrity drug-eluting stent for treating patients with diabetes. The new sizes will enable the treatment of long coronary lesions, which are generally considered to span more than 27mm, and are uniquely indicated for treating coronary artery disease in patients with diabetes, who commonly present with long lesions. Comment! [Healthcare]
Tuesday, February 19, 8:09 AM More on Medtronic (MDT) FQ3: net profit +5.7% to $988M; Sales breakdown: cardiac rhythm disease management -1% excluding currency fluctuations; spinal products -3%. Affirms 2013 guidance for EPS of $3.66-3.70 vs forecasts of $3.68 and revenue growth of 3-4% at constant currencies. Comment! [Healthcare, Earnings]
Tuesday, February 19, 7:30 AM Medtronic (MDT): FQ3 EPS of $0.93 beats by $0.02. Revenue of $4.03B (+3% Y/Y) in-line. (PR) Comment! [Earnings, Breaking News, Healthcare]
Tuesday, February 19, 12:05 AM Notable earnings before Tuesday’s open: ACT, BCRX, DCIX, FUN, GPC, MDT, MRGE, NGPC, NI, NM, ROC, SAVE, SEE, WAB, WIN, XEC, YNDX Comment! [Earnings]
Monday, February 18, 5:30 PM Notable earnings before Tuesday’s open: ACT, BCRX, DCIX, FUN, GPC, MDT, MRGE, NGPC, NI, NM, ROC, SAVE, SEE, WAB, WIN, XEC, YNDX Comment! [Earnings]
Wednesday, February 13, 3:26 PM Medtronic (MDT -0.2%) says its received FDA clearance for its AIRvance Bone Screw System, allowing surgeons to perform a hyoid suspension procedure independently or in combination with other procedures for the treatment of obstructive sleep apnea. Under its previous FDA clearance, the hyoid suspension procedure was indicated as an adjunct to the tongue suspension procedure. With this clearance, the AIRvance System becomes the only approved stand-alone system available. Comment! [Healthcare]
Wednesday, February 13, 9:55 AM The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's next-generation pacemaker that enables patients to receive MRI scans, something that is not allowed with traditional pacemakers. It's worth noting that up to 75% of patients with implanted heart devices worldwide are expected to need an MRI scan during the lifetime of those devices. (PR) Comment! [Healthcare]
Thursday, January 31, 4:09 PM Despite the marketshare gains Cardiovascular Systems (CSII) has made with its Diamondback and Stealth devices for treating narrowed or blocked arteries in the leg, the real value in the company may lie in its takeout potential, says Seeking Alpha contributor Stephen Simpson. CR Bard, Cook, BSX, JNJ, MDT and ABT all have sales forces in the peripheral treatment space, making them solid candidates for a possible buyout of CSII. Comment! [Healthcare, M&A]
Wednesday, January 30, 12:43 PM Medtronic (MDT +0.3%) says it's introduced in Europe the first and only implantable neurostimulation systems, designed for use in the treatment of chronic back or leg pain, which can be used in full-body Magnetic Resonance Imaging (MRI) scans under specific conditions. The first new system implants have been performed in Belgium, Germany, Sweden and Switzerland. Comment! [Healthcare, Global & FX]
Wednesday, January 30, 9:29 AM ARCA Biopharma (ABIO) +51.9% premarket after announcing plans for a phase 3 adaptive design clinical trial for its lead developmental drug, Gencaro, in atrial fibrillation. Medtronic (MDT) will be collaborating on the initial, phase 2B portion of the proposed trial. Comment! [Healthcare, On the Move]
Sunday, January 27, 3:30 AM Smaller medical-device makers such as Cardica (CRDC) are tacking surcharges on to their products or warning of price increases to cover a 2.3% sales tax that came into force on Jan. 1 as part of Obamacare. Larger manufacturers like Medtronic (MDT) and GE Healthcare (GE) haven't explicitly added extra fees but are expected to bake them into contract renewals.
13 Comments [Healthcare]

1
2
3
4
5
6
...
11
Next Page